These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 15312274)

  • 1. Dementia with lewy bodies: molecular pathogenesis and implications for classification.
    Cummings JL
    J Geriatr Psychiatry Neurol; 2004 Sep; 17(3):112-9. PubMed ID: 15312274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical and neuropathological characteristics of dementia with Lewy bodies].
    Bencze J; Simon V; Bereczki E; Majer R; Varkoly G; Murnyák B; Kálmán J; Hortobágyi T
    Orv Hetil; 2017 Apr; 158(17):643-652. PubMed ID: 28434243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are Parkinson's disease with dementia and dementia with Lewy bodies the same entity?
    Aarsland D; Ballard CG; Halliday G
    J Geriatr Psychiatry Neurol; 2004 Sep; 17(3):137-45. PubMed ID: 15312277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intralaminar nuclei of the thalamus in Lewy body diseases.
    Brooks D; Halliday GM
    Brain Res Bull; 2009 Feb; 78(2-3):97-104. PubMed ID: 18804518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lewy body disease, a frequent dementia].
    de la Sayette V; Viader F; Chapon F
    Bull Acad Natl Med; 2012 Feb; 196(2):445-55; discussion 455-7. PubMed ID: 23420962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dementia with Lewy bodies showing advanced Lewy pathology but minimal Alzheimer pathology--Lewy pathology causes neuronal loss inducing progressive dementia.
    Uchikado H; Iseki E; Tsuchiya K; Togo T; Katsuse O; Uéda K; Kato M; Kosaka K
    Clin Neuropathol; 2002; 21(6):269-77. PubMed ID: 12489676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapidly progressive diffuse Lewy body disease.
    Gaig C; Valldeoriola F; Gelpi E; Ezquerra M; Llufriu S; Buongiorno M; Rey MJ; Martí MJ; Graus F; Tolosa E
    Mov Disord; 2011 Jun; 26(7):1316-23. PubMed ID: 21484863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders.
    Jellinger KA
    Biochim Biophys Acta; 2009 Jul; 1792(7):730-40. PubMed ID: 18718530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abundant neuritic inclusions and microvacuolar changes in a case of diffuse Lewy body disease with the A53T mutation in the alpha-synuclein gene.
    Yamaguchi K; Cochran EJ; Murrell JR; Polymeropoulos MH; Shannon KM; Crowther RA; Goedert M; Ghetti B
    Acta Neuropathol; 2005 Sep; 110(3):298-305. PubMed ID: 15981014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The decrease of β-synuclein in cortical brain areas defines a molecular subgroup of dementia with Lewy bodies.
    Beyer K; Domingo-Sàbat M; Santos C; Tolosa E; Ferrer I; Ariza A
    Brain; 2010 Dec; 133(Pt 12):3724-33. PubMed ID: 20959308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hallucinations, somatic-functional disorders of PD-DLB as expressions of thalamic dysfunction.
    Onofrj M; Espay AJ; Bonanni L; Delli Pizzi S; Sensi SL
    Mov Disord; 2019 Aug; 34(8):1100-1111. PubMed ID: 31307115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropathological spectrum of synucleinopathies.
    Jellinger KA
    Mov Disord; 2003 Sep; 18 Suppl 6():S2-12. PubMed ID: 14502650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive impairment in Parkinson's disease and dementia with Lewy bodies.
    Aarsland D
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S144-8. PubMed ID: 26411499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visual signs and symptoms of dementia with Lewy bodies.
    Armstrong RA
    Clin Exp Optom; 2012 Nov; 95(6):621-30. PubMed ID: 22812926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dementia with Lewy bodies.
    Molano JR
    Semin Neurol; 2013 Sep; 33(4):330-5. PubMed ID: 24234353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
    Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG
    Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies.
    Ferrer I; Blanco R; Carmona M; Puig B; Barrachina M; Gómez C; Ambrosio S
    J Neural Transm (Vienna); 2001; 108(12):1383-96. PubMed ID: 11810403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dementia with Lewy bodies.
    Mayo MC; Bordelon Y
    Semin Neurol; 2014 Apr; 34(2):182-8. PubMed ID: 24963677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Parkinson's disease, dementia with Lewy bodies, multiple system atrophy and alpha-synuclein].
    Iwatsubo T
    Rinsho Shinkeigaku; 1999 Dec; 39(12):1285-6. PubMed ID: 10791099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lewy bodies, a misleading marker for Parkinson's disease?].
    Duyckaerts C; Hauw JJ
    Bull Acad Natl Med; 2003; 187(2):277-92; discussion 292-3. PubMed ID: 14556441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.